Back to Search
Start Over
MHC class I transactivator NLRC5 in host immunity, cancer and beyond
- Source :
- Immunology
- Publication Year :
- 2020
-
Abstract
- The presentation of antigenic peptides by major histocompatibility complex (MHC) class I and class II molecules is crucial for activation of the adaptive immune system. The nucleotide-binding domain and leucine-rich repeat receptor family members CIITA and NLRC5 function as the major transcriptional activators of MHC class II and class I gene expression, respectively. Since the identification of NLRC5 as the master regulator of MHC class I and class-I-related genes, there have been major advances in understanding the function of NLRC5 in infectious diseases and cancer. Here, we discuss the biological significance and mechanism of NLRC5-dependent MHC class I expression.
- Subjects :
- Inflammasomes
Immunology
chemical and pharmacologic phenomena
Adaptive Immunity
Major histocompatibility complex
Transactivation
NLRC5
Neoplasms
MHC class I
CIITA
Tumor Microenvironment
Immunology and Allergy
Animals
Humans
Gene
Enigmatic Inflammasomes: Lesser‐Studied NLRs Series
Genetics
MHC class II
biology
Histocompatibility Antigens Class I
Intracellular Signaling Peptides and Proteins
Acquired immune system
Gene Expression Regulation
biology.protein
Trans-Activators
Tumor Escape
Signal Transduction
Subjects
Details
- ISSN :
- 13652567
- Volume :
- 162
- Issue :
- 3
- Database :
- OpenAIRE
- Journal :
- Immunology
- Accession number :
- edsair.doi.dedup.....12443262d1ab054271a305722baee48e